| 2025-10-24 |
详情>>
股本变动：
变动后总股本14719.20万股
|
| 2025-10-24 |
详情>>
业绩披露：
2025年年报每股收益-0.04澳大利亚元,归母净利润-6143.42万澳大利亚元,同比去年增长-43.82%
|
| 2025-02-27 |
详情>>
业绩披露：
2025年中报每股收益-0.02澳大利亚元,归母净利润-2237.74万澳大利亚元,同比去年增长-5.41%
|
| 2024-10-22 |
详情>>
业绩披露：
2024年年报每股收益-0.04澳大利亚元,归母净利润-4271.66万澳大利亚元,同比去年增长-7.07%
|
| 2024-06-03 |
复牌提示：
2024-06-03 03:58:50 停牌，复牌日期 2024-06-05 07:05:00
|
| 2024-02-29 |
详情>>
业绩披露：
2024年中报每股收益-0.02澳大利亚元,归母净利润-2122.82万澳大利亚元,同比去年增长-2.93%
|
| 2023-10-24 |
详情>>
业绩披露：
2023年年报每股收益-0.04澳大利亚元,归母净利润-3989.63万澳大利亚元,同比去年增长-23.86%
|
| 2023-02-27 |
详情>>
业绩披露：
2023年中报每股收益-0.02澳大利亚元,归母净利润-2062.32万澳大利亚元,同比去年增长-26.75%
|
| 2022-10-31 |
详情>>
业绩披露：
2022年年报每股收益-0.04澳大利亚元,归母净利润-3221.08万澳大利亚元,同比去年增长-7.72%
|
| 2021-10-25 |
详情>>
业绩披露：
2019年年报每股收益-0.05澳大利亚元,归母净利润-1834.4万澳大利亚元,同比去年增长-43.92%
|
| 2021-10-25 |
详情>>
业绩披露：
2021年年报每股收益-0.05澳大利亚元,归母净利润-2990.26万澳大利亚元,同比去年增长-122.02%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-10-28 |
股东大会：
将于2020-10-27召开股东大会
会议内容 ▼▲
- 1.Adoption of the Remuneration Report
2.Re-election of Director - Mr Grant Chamberlain
3.Approval of additional 10% placement capacity
4.Ratification of previous Share issue
5. Approval of potential termination benefits for eligible executives of the Company
6. Approval of grant of performance rights to Mr Grant Chamberlain in lieu of cash for his directors’ fees
|
| 2020-09-25 |
详情>>
业绩披露：
2020年年报每股收益-0.03澳大利亚元,归母净利润-1346.82万澳大利亚元,同比去年增长26.58%
|
| 2019-10-01 |
股东大会：
将于2019-11-01召开股东大会
会议内容 ▼▲
- 1.Adoption of Remuneration Report
2.Re-election of Director – Mr Pete Meyers
3.Approval of additional 10% placement capacity
4.Ratification of previous Share and Warrant issue
5.Ratification of previous Share issue
6.Grant of Director Performance Rights to Mr Pete Meyers in lieu of cash fees
7.Grant of Performance Rights to Mr Marc Voigt
8.Approval of consolidation of share capital
|
| 2018-10-17 |
股东大会：
将于2018-11-16召开股东大会
会议内容 ▼▲
- 1.Adoption of Remuneration Report
2.Re-election of Director – Dr. Russell John Howard
3.Approval of additional 10% placement capacity
4.Ratification of previous Share issue
5.Approval of grant of performance rights to Dr. Russell John Howard
6.Approval of the use of performance rights and/ or options under the Company’s Executive Incentive Plan
|
| 2017-10-18 |
股东大会：
将于2017-11-17召开股东大会
会议内容 ▼▲
- 1.Non-binding resolution to adopt Remuneration Report
2.Re-election of Director – Pete Meyers
3.Re-election of Director – Grant Chamberlain
4.Approval of additional 10% placement capacity
5.Approval of grant of performance rights to Mr Grant Chamberlain
6.Approval of grant of performance rights to Mr Marc Voigt
7.Change of Company name
8.Ratification of previous Share and Warrant issue
9.Approval of termination benefits for eligible executives of the Company
|
| 2016-12-19 |
详情>>
拆分方案：
每10.0000合并分成3.0000股
|
| 2016-10-27 |
股东大会：
将于2016-11-25召开股东大会
会议内容 ▼▲
- 1.Non-binding resolution to adopt Remuneration Report
2.Re-election of Director – Dr Russell Howard
3.Grant of Director Performance Rights to Mr Pete Meyers
4.Approval of additional capacity to issue shares under ASX Listing Rule 7.1A
|
| 2015-10-23 |
股东大会：
将于2015-11-25召开股东大会
会议内容 ▼▲
- 1.Non-binding resolution to adopt Remuneration Report
2.Re-election of Director – Ms Lucy Turnbull, AO
3.Approval of the use of performance rights and/or options under the Company’s Executive Incentive Plan
4.Approval of additional capacity to issue shares under ASX Listing Rule 7.1A
|
| 2014-10-14 |
股东大会：
将于2014-11-14召开股东大会
会议内容 ▼▲
- 1.Non-binding revolution to adopt Remuneration Report
2.Re-election of Director - Mr Pete Mcym
3.Re-election of Director - Mr Marc Voigt
4.Re-election of Director - Mr Albert Wong
5.Grant of Director Performance Rights to Mr Pete Meyers
6.Grant of Director Performance Rights to Mr Marc Voigt
7.issue of shares
8.Ratification of Issue of Securities to Bergen Global Opportunity Fund, LP
9.Approval of luue of Shares to Bergen Global Opportunity Fund, LP
10.Approval of additional capacity to issue shares under ASX Listing Rule 7.1A
|